Adamson PC - Search Results

1

Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma.

Moser AM, Adamson PC, Gillespie AJ, Poplack DG, Balis FM. Moser AM, et al. Among authors: adamson pc. Cancer. 1999 Jan 15;85(2):511-6. doi: 10.1002/(sici)1097-0142(19990115)85:2<511::aid-cncr33>3.0.co;2-h. Cancer. 1999. PMID: 10023723

2

High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.

Widemann BC, Balis FM, Kempf-Bielack B, Bielack S, Pratt CB, Ferrari S, Bacci G, Craft AW, Adamson PC. Widemann BC, et al. Among authors: adamson pc. Cancer. 2004 May 15;100(10):2222-32. doi: 10.1002/cncr.20255. Cancer. 2004. PMID: 15139068 Free article.

3

Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2.

Widemann BC, Balis FM, Shalabi A, Boron M, O'Brien M, Cole DE, Jayaprakash N, Ivy P, Castle V, Muraszko K, Moertel CL, Trueworthy R, Hermann RC, Moussa A, Hinton S, Reaman G, Poplack D, Adamson PC. Widemann BC, et al. Among authors: adamson pc. J Natl Cancer Inst. 2004 Oct 20;96(20):1557-9. doi: 10.1093/jnci/djh270. J Natl Cancer Inst. 2004. PMID: 15494606

4

Dose-dependent pharmacokinetics of all-trans-retinoic acid.

Adamson PC, Balis FM, Smith MA, Murphy RF, Godwin KA, Poplack DG. Adamson PC, et al. J Natl Cancer Inst. 1992 Sep 2;84(17):1332-5. doi: 10.1093/jnci/84.17.1332. J Natl Cancer Inst. 1992. PMID: 1495103

5

A phase II trial of continuous-infusion 6-mercaptopurine for childhood leukemia.

Adamson PC, Zimm S, Ragab AH, Balis F, Steinberg SM, Kamen BA, Vietti TJ, Gillespie A, Poplack DG. Adamson PC, et al. Cancer Chemother Pharmacol. 1992;30(2):155-7. doi: 10.1007/BF00686410. Cancer Chemother Pharmacol. 1992. PMID: 1600597 Clinical Trial.

6

Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule.

Adamson PC, Balis FM, Miser J, Arndt C, Wells RJ, Gillespie A, Aronson L, Penta JS, Clendeninn NJ, Poplack DG. Adamson PC, et al. Cancer Res. 1992 Feb 1;52(3):521-4. Cancer Res. 1992. PMID: 1732038 Clinical Trial.

7

Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic study.

Adamson PC, Balis FM, Arndt CA, Holcenberg JS, Narang PK, Murphy RF, Gillespie AJ, Poplack DG. Adamson PC, et al. Cancer Res. 1991 Nov 15;51(22):6079-83. Cancer Res. 1991. PMID: 1933871 Clinical Trial.

8

The child with recurrent solid tumor.

Adamson PC, Horowitz ME, Poplack DG. Adamson PC, et al. Pediatr Clin North Am. 1991 Apr;38(2):489-504. doi: 10.1016/s0031-3955(16)38089-0. Pediatr Clin North Am. 1991. PMID: 2006087 Review.

9

A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumors.

Adamson PC, Zimm S, Ragab AH, Steinberg SM, Balis F, Kamen BA, Vietti TJ, Gillespie A, Poplack DG. Adamson PC, et al. Cancer Chemother Pharmacol. 1990;26(5):343-4. doi: 10.1007/BF02897290. Cancer Chemother Pharmacol. 1990. PMID: 2208575

10

Pharmacology and drug resistance in childhood lymphoblastic leukemia.

Adamson PC, Poplack DG, Balis FM. Adamson PC, et al. Hematol Oncol Clin North Am. 1990 Oct;4(5):871-94. Hematol Oncol Clin North Am. 1990. PMID: 2262483 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

312 results

Search Page